Enable Biosciences is a pioneering brand in the field of biosciences, offering innovative products and services that revolutionize the healthcare industry. Led by a team of exceptional experts, Enable Biosciences is committed to pushing the boundaries of scientific research and advancing diagnostics. The executive team, including Co-founder and Chair, Carolyn Bertozzi, a world-renowned Professor of Chemistry at Stanford, and Chief Executive Officer David Seftel, a seasoned clinician and entrepreneur, brings extensive knowledge and experience to the brand.

Jason Tsai and Peter Robinson, Co-founders and Chief Technology Officer and Chief Operating Officer respectively, contribute their expertise in immunology, protein biochemistry, and molecular biology. Enable Biosciences offers a range of cutting-edge products and services, including the core ADAP technology developed by Jason Tsai. This technology enables the detection of glycoproteins and antibodies, providing valuable insights for molecular diagnostics.

With a dedicated research team and state-of-the-art laboratory, Enable Biosciences continues to innovate and develop new solutions to address the most pressing healthcare challenges. The clinical team, led by Laboratory Director Lynette Sawyer DPH, ensures the highest quality standards in laboratory testing. With their comprehensive expertise in virology and clinical laboratory science, they play a crucial role in the accurate diagnosis and monitoring of diseases.

Enable Biosciences is at the forefront of the healthcare industry, driving advancements in diagnostics and paving the way for a healthier future